Aleksandar Danilovski
Director/Board Member at ACTIVE BIOTECH AB
Aleksandar Danilovski active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACTIVE BIOTECH AB | Director/Board Member | 2019-12-31 | - |
| Independent Dir/Board Member | 2019-12-31 | - | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Chief Tech/Sci/R&D Officer | 2019-12-31 | - |
| Pharmaero ApS | Director/Board Member | - | - |
Career history of Aleksandar Danilovski
Former positions of Aleksandar Danilovski
| Companies | Position | Start | End |
|---|---|---|---|
| PLIVA Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Corporate Officer/Principal | - | - |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Corporate Officer/Principal | - | - |
| PLIVA Croatia Ltd. | Director/Board Member | 2012-01-08 | - |
| Corporate Officer/Principal | - | 2012-01-08 | |
| The Barr Group, Inc. | Corporate Officer/Principal | 1993-12-31 | - |
PLIVA, Inc.
 PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 1993-12-31 | - |
Training of Aleksandar Danilovski
| University of Cambridge | Doctorate Degree |
| University of Zagreb | Doctorate Degree |
Statistics
International
| United States | 5 |
| Sweden | 3 |
| United Kingdom | 3 |
Operational
| Corporate Officer/Principal | 6 |
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Private companies | 8 |
|---|---|
PLIVA, Inc.
PLIVA, Inc. Drugstore ChainsRetail Trade PLIVA, Inc. develops, produces, and sells drugs and pharmaceutical products. Its products include Ethosuximide, Fluoxetine, and Cyclosporine. The company was founded in 1921 and is headquartered in East Hanover, NJ. | Retail Trade |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Health Technology |
| PLIVA Pharmaceuticals, Inc. | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Services |
| The Barr Group, Inc. | |
| PLIVA Croatia Ltd. | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
| Pharmaero ApS |
